DSM CAPITAL PARTNERS LLC – Neurocrine Biosciences, Inc. Transaction History
DSM CAPITAL PARTNERS LLC portfolio value:
$140.43M
portfolio value
DSM CAPITAL PARTNERS LLC quarter portfolio value change:
+8.96%
quarter
Neurocrine Biosciences, Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Decrease | -0.70% | -9.25K shares | 10.64M | $106.21 | 1.32M |
| Q2 2022 | share | Decrease | -1.47% | -19.87K shares | 3.10M | $97.48 | 1.33M |
| Q1 2022 | share | Decrease | -4.04% | -56.86K shares | 6.75M | $93.75 | 1.35M |
| Q4 2021 | share | Decrease | -6.93% | -104.91K shares | -25.54M | $84.63 | 1.40M |
| Q3 2021 | share | Decrease | -1.46% | -22.37K shares | -3.95M | $95.91 | 1.51M |
| Q2 2021 | share | Increase | +13.87% | 186.97K shares | 18.29M | $97.32 | 1.53M |
| Q1 2021 | share | Increase | +20.79% | 232.12K shares | 24.13M | $97.25 | 1.34M |
| Q4 2020 | share | Increase | +33.42% | 279.61K shares | 26.54M | $95.85 | 1.11M |
| Q3 2020 | share | Decrease | -3.33% | -28.84K shares | -25.14M | $96.16 | 836.76K |
| Q2 2020 | share | Increase | +0.65% | 5.56K shares | 31.16M | $122 | 865.61K |
| Q1 2020 | share | Increase | +28.26% | 189.50K shares | 2.36M | $86.55 | 860.05K |
| Q4 2019 | share | Increase | +2.97% | 19.33K shares | 13.39M | $107.49 | 670.54K |
| Q3 2019 | share | Decrease | -1.41% | -9.31K shares | 2.91M | $90.11 | 651.21K |
| Q2 2019 | share | Decrease | -5.12% | -35.65K shares | -5.56M | $84.43 | 660.52K |
| Q1 2019 | share | Increase | 0.00% | 696.18K shares | 61.33M | $88.1 | 696.18K |